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7.1 Introduction
Why is chemical modification of chitosan needed? The partial answer to this questionmay be explained by the
low hemocompatibility and water-insoluble nature of chitosan. Additionally, modification is required in order
tomanipulate other properties of chitosan tomeet specific needs. Chitosan is a polysaccharide obtainedmainly
from crustacean shells and is composed of 2-amino-2-deoxy-b-D-glucan combined with glycosidic linkages.
The primary amine groups render special properties that make chitosan very useful in pharmaceutical
applications. Chitosan’s nontoxicity, biodegradability, and biocompatibility make it suitable for various
biomedical applications such as in drug delivery [1–4], gene delivery [5,6], wound dressing [7–11], and tissue
engineering [12,13]. Given the wide and diverse range of potential applications, chitosan may be chemically
modified so as to maximize the polymer processability, solubility, the antimicrobial activity, and ability to
interact with other substances. Modified chitosan is expected to show different features from those of native
chitosan. With regard to drug delivery applications, the new properties of modified derivatives include
enhanced solubility in water and thereby better biodistribution or bioavailability when they are administered
parenterally. For example, carboxymethylation of chitosan increases the solubility of chitosan at neutral and
alkaline pH valueswithout affecting other important characteristics [14–19]. The hemocompatibilitymay also
be increased as the positive charge of the system is reduced.
Important chemical modification methods of chitosan are discussed in this chapter, including carbox-
ymethylation, thiolation, succinylation, grafting, and copolymerization, among others. This chapter also
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intends to systematize related issues, including the various methods of chitosan grafting and their formulation
for drug delivery [20]. In recent years, much attention has been given to water-soluble, stimuli-responsive
polymeric systems based on chitosan, which show a phase transition in response to external stimuli such as
temperature, pH, specific ion concentration, and electric field [21]. Among all the studied stimuli-sensitive
materials, temperature- and pH-responsive polymers have drawn the most attention, because these are
important physiological factors in the body, and some diseases manifest themselves by changes in either
temperature or pH, or even both [21]. In particular, several research groups have reported on the preparation
of pH- and temperature-sensitive polymers based on poly(N-isopropylacrylamide) (PNIPAAm) and poly
(N-vinylcaprolactam) (PNVCL) for biomedical applications, where PNVCL showed a better defined response
toward temperature than PNIPAAm [3,22]. Thus, in the current chapter, an overview on the drug delivery
applications of cross-linked [23] and chemically modified chitosan is given. Important modified and
cross-linked derivatives include carboxymethyl-chitosan (CMC), O-carboxymethyl-chitosan (O-CMC),
N,O-carboxymethyl-chitosan (N,O-CMC) and N-carboxymethyl-chitosan (N-CMC) [14–19], succinyl-
chitosan [24–32], thiolated chitosan [33–43], and chitosan grafted with PNIPAAm and PNVCL (chitosan-
g-PNIPAAm and chitosan-g-PNVCL) [44–47].
7.2 General Awareness of Chitosan Cross-Linking Methods
7.2.1 Chemical Cross-Linking
Cross-linking happens when a chemical or compound, referred to as the “cross-linker,” makes intermolecular
covalent bridges between the polymer chains [23]. Chemical cross-linkers include glutaraldehyde, genipin,
glyoxal, dextran sulfate, 1,1,3,3-tetramethoxypropane, oxidized cylclodextrins, ethylene glycoldiglyceryl
ether, ethylene glycol diglycidyl ether (EGDE), and diisocyanate, among others [23]. Some of the commonly
used cross-linking agents will be discussed below.
7.2.1.1 Glutaraldehyde
Glutaraldehyde (Figure 7.1) can easily cross-link with chitosan, because of its active aldehyde groups.
The mechanism involves the formation of Schiff’s base via nucleophilic attack by the nitrogen of the amino
group (from chitosan) on the carbon of the glutaraldehyde, which displaces the oxygen of the aldehyde
resulting in the C¼N bond [23]. However, there are concerns with the use of glutaraldehyde as it is suspected
to impart toxicity, which may result in the decline of biocompatibility of systems [48].
Several studies have reported on the use of glutaraldehyde as a cross-linker for chitosan-basedmaterials. For
instance, glutaraldehyde cross-linked chitosan–poly(vinyl alcohol) (PVA) hydrogels were developed as
injectable drug delivery systems [49]. Also, pH-responsive, freeze-dried chitosan–polyvinyl pyrrolidone
(PVP) hydrogels [50] and chitosan–PVA hydrogels [51] were developed for drug delivery applications by
cross-linking with glutaraldehyde. The potential of post cross-linking of chitosan, after preparing a semi-
interpenetrating polymer network (semi-IPN) with PNIPAAm to create temperature-responsive and pH-
sensitive IPNs for drug delivery, has also been studied [44]. Further, CMC [52] and N-(2-carboxybenzyl)-
chitosan hydrogels [53] have been prepared by reacting glutaraldehydewith the respective chitosan derivative.
Figure 7.1 Chemical structure of glutaraldehyde.
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Hydrogels of poly(ethylene glycol) (PEG)-grafted-chitosan cross-linked with glutaraldehydewere developed
for drug delivery [51]. Poly(N-acryloylglycine-chitosan) hydrogels were also developed by irradiating the
solution of N-acryloglycine mixed with chitosan in the presence of glutaraldehyde as a cross-linker and 2,2-
dimethoxy-2-phenyl acetophenone as a photo-initiator [54].
Glutaraldehyde cross-linked chitosan beads for drug delivery were obtained by extruding chitosan–-
PEG [55], chitosan–glycine [56], chitosan–alanine [57], and chitosan–PVP [58] solutions as droplets into a
sodium hydroxide–methanol solution. Resulting beads were washed with water and cross-linked with
glutaraldehyde. In another work, glutaraldehyde cross-linked chitosan-based beads were developed in a
simple way, by using a chitosan solution containing glutaraldehyde to form beads in sodium hydroxide
solution [59]. Semi-IPN microspheres of acrylamide-g-chitosan were developed by adding solutions of
acrylamide-g-chitosan to paraffin [60]. The required amount of glutaraldehyde was added to the resulting
emulsion under stirring in order to cross-link the microspheres.
7.2.1.2 Genipin
One of the relatively new cross-linking agents is the naturally occurring substance genipin (Figure 7.2). It is an
excellent cross-linker for polymers containing amino groups and forms a blue gel upon spontaneous reaction
with amino groups [61]. As a result, genipin cross-linked chitosan hydrogels have a bluish appearance.
The cross-linking mechanism involves a nucleophilic attack by the amino group of chitosan on to the olefinic
carbon atom atC-3 of genipin, followed by the opening of the dihydropyran ring. The formation of a secondary
amide and a heterocyclic amino linkage leads to the cross-linking of chitosan [62].
Different examples of the use of genipin as a cross-linker of chitosan have been reported. For example,
genipin was used for cross-linking chitosan and chitosan–poly(ethylene oxide) by mixing the corresponding
polymer solutions with genipin [62]. Genipin cross-linked chitosan microspheres were also prepared by other
techniques like spray drying [63] or water-in-oil emulsion [64,65]. Hydrogels of O-CMC–alginate were
developed by cross-linking with genipin for protein drug delivery [64]. In another example, chitosan–alginate
beads were developed by dropping chitosan solution into a gelling bath containing a mixture of alginate and
genipin [66].
7.2.1.3 Glyoxal
Glyoxal (Figure 7.3) can cross-link chitosan in the same way as glutaraldehyde (Figure 7.4). Selected
examples of its use as a cross-linker of chitosan include the preparation of enantioselective L-aspartic acid-
imprinted chitosan [67] and superporous chitosan hydrogels [68].
7.2.1.4 Dextran Sulfate
Dextran sulfate is a biocompatible polyanionic polymer. It is a highly branched polysaccharide (Figure 7.5)
with 1–6 and 1–4 glycosidic linkages,with approximately 2.3 sulfate groups per glucosyl unit. It is widely used
in medical field as a plasma volume expander. Several preparations of dextran sulfate have shown promising
Figure 7.2 Chemical structure of genipin.
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anticoagulant [69] and fibrinolytic [70] activity. Dextran sulfate can also be used as a cross-linker for chitosan.
For instance, chitosan–dextran sulfate micro- and nanoparticles were formed by the electrostatic interaction
between the protonated amino groups of chitosan and the sulfate groups of dextran sulfate. These particles
were used for controlled drug delivery applications since the synthesis route is simple and can be done in
mild conditions [71,72]. The surface charge of this type of particles were tunable by varying the ratio of the
two-polymer concentrations [73]; also, prepared particles have good stability and do not need any stabilization
or additional cross-linking agent. Chitosan–dextran sulfate nanoparticles have been reported for the oral
delivery of insulin [74], intravenous delivery of antiangiogenic peptides [75], and controlled delivery of
low–molecular weight (MW) drugs [76].
7.2.1.5 Bifunctional Cross-linking Agents
In addition to glutaraldehyde and genipin, numerous bifunctional reagents have been used to cross-link
chitosan covalently, such as epichlorohydrin, diisocyanate (Figure 7.6), or epoxy compounds, 4-butanediol
diglycidyl ether or ethylene glycol diglycidyl ether (EGDE; Figure 7.6) [77]. Among those bifunctional
Figure 7.3 Chemical structure of glyoxal.
Figure 7.4 A description of the mechanism for glyoxal cross-linking of chitosan. Glyoxal reacts with hydroxyl
groups (a) and amino groups (b) in chitosan. Redrawn from reference [67].
Figure 7.5 Chemical structure of dextran sulfate.
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reagents, EGDEmay be themost suitable cross-linker for reaction with chitosan to prepare flexible films. This
is based on the observation that while cross-linking with glutaraldehyde increased the tensile strength and
decreased the elongation of 6-O-CMC–water-soluble polyurethane (WPU) composite membranes, the
elongation of 6-O-CMC–WPU membranes increased upon reaction with EGDE [78]. Recently, a novel
biodegradable stent made of chitosan–poly(ethylene oxide) blended films cross-linked with EGDE, which
exhibited shape memory characteristics, was developed for the sustained release of sirolimus [79].
7.2.2 Radiation Cross-Linking
Radiation cross-linking does not require heat or a catalyst; thus, no additional toxic chemical is introduced into
the system. Radiation polymerization has been utilized by researchers to obtain IPNs for drug delivery
applications [80–83]. Also, photo-cross-linkable chitosan was developed by introducing azide and lactose
moieties on chitosan through a condensation reaction [84], and these hydrogels found applications in the
release of fibroblast growth factors and heparin [85].
7.2.3 Physical Cross-Linking
In contrast to covalent bonding of chemical cross-linking, physical cross-linking is obtained by using
cross-linkers that establish ionic interactions between the polymer chains. Two well-recognized examples
of physical cross-linkers of chitosan are pentasodium tripolyphosphate (TPP) and calcium chloride.
7.2.3.1 Pentasodium Tripolyphosphate
TPP (Figure 7.7) is a well-known cross-linking agent for the preparation of micro- and nanoparticles of
chitosan and its derivatives [18,45,86,87]. For instance, 5-flourouracil-loaded chitosan-g-PNVCL nanopar-
ticles [88], gliclazide-loaded chitosan microparticles [89], rifampicin- and hydroxyurea-loaded chitosan
microspheres [90], and exotoxin–chitosanmicroparticles obtained by spray drying were developed using TPP
as a cross-linker [91].
7.2.3.2 Calcium Chloride
This is a well-known physical cross-linker for a variety of materials having one or more active carboxyl
functionalities, including alginate, O-CMC, and N,O-CMC, among others. One of the actual interests in
Figure 7.6 Structure of ethylene glycol diglycidylether (EGDE) (a) and of diisocyanate (b).
Figure 7.7 Chemical structure of pentasodium tripolyphosphate (TPP).
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calciumchloride, among others, is connectedwith its chelating abilitywithminimal or negligible toxicity [18].
The formulation of nanosystems of polysaccharide derivatives using calciumchloridewill be discussed later in
this chapter.
7.3 Modified Chitosan: Synthesis and Characterization
7.3.1 Synthesis of Water-soluble Chitosan Derivatives
7.3.1.1 Carboxymethylation
One of themost important chemical modificationmethods of chitosan is carboxymethylation. Carboxymethyl
derivatives of chitosan (CMC) were found to be nontoxic, anionic, and water soluble. Because of these
excellent properties, CMC found applications in biomedical and environmental fields [14,92–95]. Depending
on the position of the carboxymethyl substitution, these derivatives can be classified asO-CMC, N-CMC, and
N,O-CMC [14,93].
The synthesis protocol for O-CMC is well described [14,16,17], and it involves the carboxymethylation
reaction of chitosan powder with monochloroacetic acid using isopropyl alcohol as the solvent system. The
reaction procedure involves the treatment of chitosan with 50% sodium hydroxide solution at 18C for 12 h
followed by the reaction with chloroacetic acid. Depending on the experimental conditions, such as the
reaction temperature, carboxymethyl derivatives with different degrees of substitution may be obtained [14].
The reaction scheme for the synthesis of O-CMC from chitosan is depicted in Figure 7.8.
The synthesis protocol forN-CMC is alsowell described [14,96]. It involves the formation of an aldimine by
the reaction of the free amino groups of chitosanwith glyoxylic acid, followed by the reduction of the aldimine
product by sodium cyanoborohydride [14,96]. The reaction scheme is depicted in Figure 7.9.
A number of reports on the synthesis of N,O-CMC from chitosan is available [14,19,97]. The synthesis
involves the substitution by carboxymethyl groups of some of the amino and primary hydroxyl sites of the
glucosamine units of the chitosan structure. It involves the carboxymethylation of chitosan using mono-
chloroacetic acid in alkaline medium (Figure 7.10).N,O-CMC is hydrophilic and a typical kind of amphoteric
polyelectrolyte with antibacterial effect [98]. It is an excellent candidate for the preparation of membrane
Figure7.8 Reaction scheme showing the synthesis ofO-CMC fromchitosan.Adapted from [14], Copyright (2010),
with permission from Elsevier.
Figure7.9 Reaction scheme showing the synthesis ofN-CMC fromchitosan. Adapted from [14], Copyright (2010),
with permission from Elsevier.
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materials, which are used in filtration processes [99]. Nanoparticles ofO-CMC [2,4,18] andN,O-CMC [18,19]
have been prepared via the cross-linking reaction with CaCl2 and TPP, respectively.
7.3.2 Thiolation
Thiolated chitosan is obtained by the substitution with thiol-bearing moieties of the chitosan backbone
(position 2 of the glucosamine subunits of chitosan) via the formation of amide or amidine bonds
(Figure 7.11) [34,36,40–42]. Depending upon the agents used for thiolation, different thiolated chitosan
derivatives can be obtained. These include chitosan–thioglycolic acid conjugates [41,42], chitosan–cysteine
conjugates [36,40]. and chitosan-4-thio-butyl-amidine conjugates [34]. In the case of the formation of amide
bonds, the carboxylic acid group of the ligands cysteine and thioglycolic acid reacts with the primary amino
group of chitosan as mediated by a water-soluble carbodiimide. Thiolation reaction with Traut’s reagent
(2-iminothiolane) has the advantages of being a one-step reaction and protecting the thiolating agent
from oxidation. The degree of thiol substitution in thiolated chitosan can be obtained based on Ellman’s
method for assaying thiols [33–43]. Thiolated chitosan possesses better mucoadhesiveness and permeation
properties as compared to unmodified chitosan [33–43]. The improved mucoadhesion of thiolated chitosan
can be explained based on the fact that there is the possibility of formation of covalent bonds between thiol
groups of the polymer and cysteine-rich subdomains of glycoproteins in the mucus layer. These covalent
bonds were reported to be stronger than noncovalent bonds, such as the ionic interactions established
between chitosan and the anionic substructures of the mucus layer. Nanoparticles of thiolated chitosan may
be obtained as a result of an ionic cross-linking reaction of thiolated chitosan with TPP [100]. Thiolated
chitosan nanoparticles have been studied for applications in drug delivery as well as for permeation
enhancement [33–43].
7.3.3 Succinylation
The general reaction for the obtention ofN-succinyl–chitosan is showed in Figure 7.12. One of the important
succinyl–chitosans, N-succinyl-N0-octyl-chitosan [32], which can form micelles in an aqueous media, has
been prepared by modifying the amino group with a hydrophobic long-chain alkyl functionality and a
hydrophilic succinylmoiety [47].Anamphiphilicderivativeof succinyl–chitosanhasalsobeenreported [29].
The results showed that the modified chitosan ((2-hydroxypropyl-3-butoxy)-propyl-succinyl-chitosan)
can concentrate on the surface of water to decrease the surface tension and can associate with hydrophobic
chains to form aggregates in the solution. The abilities to decrease the surface tension and to form aggre-
gates were promoted by increasing the degree of substitution of the hydrophobic group and the addition of
salt [29]. Synthesis and evaluation ofN-succinyl–chitosan nanoparticles toward local hydroxycamptothecin
delivery have also been reported [32]. The synthesized N-succinyl–chitosan derivative, which could self-
aggregate to form nanoparticles in distilled water, found potential application for hydrophobic anticancer
drug delivery.
Figure 7.10 Reaction scheme showing the synthesis of N,O-CMC from chitosan. Adapted from [14], Copyright
(2010), with permission from Elsevier.
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Figure 7.11 Different thiol functionalization strategies for chitosan.
Figure 7.12 Reaction scheme for the synthesis of succinyl–chitosan from chitosan.
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7.3.4 Chitosan-Grafted Polymers
According to the International Union of Pure and Applied Chemistry (IUPAC), grafting in polymer chemistry
refers to the reaction in which one or more species of blocks are connected to the chain of a macromolecule as
side chains, having constitutional or configurational features that differ from those in the main chain. In
general, grafting can improve the properties of materials by controlling various parameters, namely, the co-
monomer ratio, solvent concentration, and temperature, among others. Depending on the requirement, novel
properties such as enhanced water solubility, lower critical solution temperature (LCST), improved drug-
loading capacity, and hemocompatibility can be achieved. Grafting of chitosan with different functionalities
may improve the biomedical applications especially in drug delivery [101–106]. Some of the grafting
techniques for chitosan are discussed in the following subsections.
7.3.4.1 Grafting Initiated by Free Radicals
In recent years, a number of initiators, such as ammonium persulfate (APS), potassium persulfate (PPS. or
K2S2O8), ceric ammonium nitrate (CAN), thiocarbonate–potassium bromate (TCPB), potassium diperioda-
tocuprate (III) (PDC), 2,20-azobisisobutyronitrile (AIBN), and ferrous ammonium sulfate (FAS), have been
developed for grafting copolymerization [104,105]. For example, using PPS and sodiumbisulfite (NaHSO3) as
redox initiators, 4-vinylpyridine was grafted onto chitosan under homogeneous as well as heterogeneous
conditions [104]. In another work, a thermosensitive hydrogel was developed by block copolymerization of
monomethoxy-poly(ethylene glycol) onto a chitosan (chitosan–PEG) backbone, using PPS as a free radical
initiator [105]. The prepared block copolymer exhibited a thermoreversible transition from an injectable
solution at low temperature to a gel at body temperature. The study of the gelation behavior showed the
applicability of chitosan–PEG block copolymers in the biomedical field. In addition to the stated examples,
several important grafting examples of chitosan are presented in Table 7.1.
7.3.4.2 Radiation-Induced Grafting
In addition to free radical initiators, radiation has also been used to induce the grafting of several natural
polymers. In one study, graft copolymerization of butyl acrylate onto chitosan has been performed using
g-irradiation [116]. It was found that the grafting percentage increased when the monomer concentration and
total radiation dose increased or when the chitosan concentration and reaction temperature decreased.
Table 7.1 Free Radical–Initiated Grafting Techniques for Chitosan
Co-monomer or -polymer Initiators used References
Poly(4-vinylpyridine) APS [106]
Poly(3-hydroxy-butylate) APS [107]
Polyaniline APS [108]
Vinyl acetate CAN [101]
Polyacrylamide CAN [102]
Poly(acrylic acid) CAN [102,106]
Poly(4-vinylpyridine) CAN [106]
N,N-dimethyl-N-methacryloxyethyl-N-(3-sulfopropyl) ammonium CAN [109]
Poly(acrylonitrile) CAN [110]
2-Hydroxy-ethyl-methacrylate CAN [111]
Vinyl pyrrolidone PPS [106]
Acrylonitrile PPS [112]
2-Acrylamide-2-methyl-propanesulfonic acid PPS [114]
Methyl acrylate PDC [113]
Vinyl monomers AIBN [103,115]
AIBN: 2,20-azobisisobutyronitrile; APS: ammonium persulfate; CAN: ceric ammonium nitrate; PDC: potassium diperiodatocuprate (III); and PPS:
potassium persulfate.
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Similar work has also been reported for grafting chitosan with poly(hydroxyethyl methacrylate) (PHEMA) in
the presence of UV light [117]. In this case, sulfite oxidase enzyme was then covalently immobilized onto
the matrix of the grafted polymer. After the completion of the photo-induced polymerization reaction,
p-benzoquinone was coupled onto the polymer network for activation of the chitosan–PHEMA copolymer.
This study highlighted the feasibility of using chitosan for electrochemical biosensor applications [117].
Microwave irradiation has also been used for grafting chitosan with polyacrylonitrile [118]. The effects of
reaction variables, such as monomer or chitosan concentration, microwave power, and exposure time on the
graft copolymerization, were studied. Parameters such as solvent composition, monomer concentration,
radiation dose rate, and total dose and time were found to affect the rate of grafting and homopolymerization.
7.3.4.3 Enzymatic Grafting
Grafting techniques by enzymes allow for a number of advantages in the synthesis of polymers [119]. Enzymes
can selectively and specifically eliminate the hazards associatedwith chemical reagents.Also, they canmodify
themacromolecular structure, thereby enhancing the polymer function [119–123]. Enzymatic modification of
chitosan results in derivativeswith unique pH-sensitive, water-soluble, and adhesive properties. For instances,
tyrosinase enzyme can effectively graft phenolic compounds onto chitosan, thus conferring water solubility
under basic conditions [122]. In slightly acidic media (pH 6), chitosan could be modified under homogeneous
conditions with the natural product chlorogenic acid. The modified chitosan was soluble under both acid and
basic conditions, even when the degree of modification was low. Since it is possible for quinones to undergo
either or both type of reactions with amines, as well as oligomer-forming reactions with other quinones, it is
common for reactions between quinones and amines to yield complex mixtures of products [122].
In one report, the feasibility of using tyrosinase as a catalyst for grafting hexyloxyphenol onto chitosan was
investigated [123]. The method employed tyrosinase to convert the phenol into a reactive o-quinone, which
undergoes a subsequent non-enzymatic reaction with chitosan under homogeneous conditions. The hetero-
geneous modification of a chitosan film was found to produce a hydrophobic surface due to the substituent,
while homogeneously modified chitosan exhibited rheological properties characteristic of associating water-
soluble polymers. In order to confer functional properties to chitosan, horseradish peroxidase has also been
used as a catalyst in grafting reactions [121].
7.3.4.4 Cationic Graft Polymerization
The grafting reaction onto chitosan is also performed by using living cationic polymerization. Grafting of
chitosan with living poly(isobutylvinyl ether) and poly(2-methyl-2-oxazoline) cations with controlled
molecular weight distribution has been reported [124]. In this study, researchers have analyzed the effect
of the molecular weight of living polymer cations on the number of grafted polymers; it was found that the
number of grafted polymer chains decreased with the increasing molecular weight of living polymer cations.
7.3.4.5 Chitosan-Grafted Thermosensitive Polymers
Synthesis and self-assembly of tunable thermosensitive chitosan amphiphilic copolymers have been reported
via click chemistry [125]. In this way, chitosan grafted with copolymers of 2-(2-methoxyethoxy)ethyl
methacrylate (MEO2MA) and oligo(ethylene glycol) methacrylate (OEGMA) (chitosan-g-P(MEO2MA-co-
OEGMA)) was synthesized by the “graft onto” method via click chemistry. It was observed that amphiphilic
chitosan-g-P(MEO2MA-co-OEGMA) can be assembled into micelles in water. The self-assembling behavior
and tunable thermosensitive properties of chitosan copolymermicelles were investigated. The LCST values of
micelle solutions were able to be tuned by altering the molar ratio of MEO2MA and OEGMA. The micelles
could also reversibly swell and shrink in response to external temperature. The obtained thermosensitive
amphiphilic graft copolymers have both the unique properties of P(MEO2MA-co-OEGMA) and chitosan,
which can be utilized for thermoresponsive drug delivery in combination with different thermal ablation
therapies [125].
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Anovelmagnetic nanoparticle drug carrier for controlled drug release has been reported to respond to changes
in external temperature or pH, resulting in longer circulation time and reduced side effects of the delivered drug
(doxorubicin) as compared to the native drug [126]. The novel nanocarrier is described as a functionalized
magnetite (Fe3O4) core that is conjugated with doxorubicin via an acid-labile hydrazone bond and encapsulated
by the thermosensitive smart polymer, chitosan-g-poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide).
ThedevelopedsmartpolymerexhibitedaLCSTof38C.Thedrugreleasewasappreciably lowbelowtheLCSTas
opposed to temperatures above the LCST. In each case, there was an initial rapid drug release, followed by a
controlled release in a second stage, especially in a mild acidic buffer solution [126].
7.3.4.6 Nanoparticles Produced with Chitosan-Grafted Thermosensitive Polymers
Recently, chitosan-g-PNVCLnanoparticles have been reported as carrier systems for 5-flourouracil usingTPP
as a cross-linker [45]. The synthetic route for obtaining the modified chitosan is presented in Figure 7.13.
Nanoparticles showed an excellent hemocompatibility after 4 h of incubation with erythrocytes, thus
Figure 7.13 The reaction scheme for the synthesis of chitosan-g-PNVCL using a 1-ethyl-3-(3-dimethylamino-
propyl) carbodiimide (EDC)–N-hydroxysuccinimide (NHS) mediated amidation reaction. Redrawn from
reference [45].
Figure 7.14 The reaction scheme for the synthesis of chitosan-g-PNIPAAm using a 1-ethyl-3-(3-dimethylamino-
propyl) carbodiimide (EDC)–N-hydroxysuccinimide (NHS) mediated amidation reaction. Reprinted from [127],
Copyright (2011), with permission from Elsevier.
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suggesting that intravenous administration of these formulations may be possible. In addition, it has been
reported that the modified chitosan may be useful for both hydrophobic [88] and hydrophilic drug
encapsulation [45] via a thermosensitive drug releasemechanism. Also, nanoparticles produced with chitosan
modifiedwith PNIPAAm–COOH (chitosan-g-PNIPAAm)were developed for the delivery of curcumin [127].
The synthetic route for obtaining the modified chitosan is presented in Figure 7.14. TPP was used as a cross-
linker to obtain the nanoparticles. Interesting results were observed when using nanoparticles, namely, the
specific toxicity of curcumin toward cancer cells [127].
7.4 Applications of Modified Chitosan and Its Derivatives in Drug Delivery
The major applications of modified as well as cross-linked chitosan involve the development of the
nanoformulations, which can act as improved therapeutic carrier systems for drug delivery. The advantages
of modified and cross-linked nanoformulations include high solubility, good loading efficiency, and more
sensitivity to release the drugs at different pH values. Several examples are described in this section.
Alginate–folic acid-modified chitosan nanoparticles were developed by a TPP cross-linking method for the
photodynamic detection of intestinal neoplasm [128]. In another work, saponin-loaded chitosan–TPP
nanoparticles were developed and showed increased toxicity toward cancer cells [129]. In another report,
5-aminosalicylic acid-loaded carboxymethyl chitosan–starch nanoparticles were developed via a complex
coacervation process for colon-specific drug delivery [130]. 5-fluorouracil-loaded folate-conjugated manga-
nese-doped zinc sulfide-O-carboxymethyl chitosan nanoparticles were reported by our group for targeted drug
delivery, with potential usefulness in cancer therapy [2]. From our studies [129], it was confirmed that the
systemwas able to deliver the anticancer drug (5-fluorouracil) alongwith simultaneous imaging of cancer cells
without affecting theirmetabolic activity andmorphology under in vitro conditions. In another work,mono-N-
carboxymethyl chitosan (MCC) andN-trimethyl chitosan (TMC) nanoparticles have been developed for non-
invasive vaccine delivery [131]. TMC–MCC nanocomplexes have also been used as carriers for the mucosal
delivery of vaccines [132].
7.5 Conclusions and Future Perspectives
In the current chapter, we provide an overview of various cross-linked as well as chemicallymodified chitosan
derivatives and their processing routes with special consideration to drug delivery applications. In particular,
the drug delivery applicability of micro- and nanoparticles of cross-linked as well as chemically
modified chitosan derivatives have been discussed. In general, these materials are biocompatible and
hemocompatible even after modification, and they possess novel properties such as higher drug-loading
efficacy and water solubility. The future scope of these materials can be extended for targeted cancer therapy.
The preliminary results from many of the studies on modified chitosan materials strongly support their
potential as versatile and effective drug delivery systems and warrant ongoing research in both in vivo and
preclinical models.
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